NCT07489950

Brief Summary

Title: Validating the Accuracy of Lung Blood Flow Monitoring Without Breath-Holding Under Spontaneous Breathing Support Purpose: The purpose of this study is to evaluate the accuracy of a new Electrical Impedance Tomography (EIT) technique that measures lung blood flow (perfusion) without requiring patients to hold their breath. We aim to determine if this "non-apnea" method provides results consistent with the current clinical gold standard (the "pause" method). Background: EIT is a non-invasive bedside tool used to monitor lung function. The traditional method for measuring lung blood flow requires patients to hold their breath for 5-8 seconds during a saline injection to avoid interference from breathing. However, many patients-especially those using a nasal cannula, high-flow nasal oxygen (HFNO), or pressure support ventilation (PSV)-must maintain continuous spontaneous breathing and find it difficult or unsafe to hold their breath. If a "non-apnea" method is proven accurate, it will make monitoring safer and easier for these patients. What the Study Involves: The study includes stable adult patients who are breathing spontaneously. Each patient undergoes two measurements in a randomized order: Standard Reference (Pause Method): Measurement taken during a brief, guided breath-hold. Test Method (Non-Apnea Method): Measurement taken during normal, uninterrupted breathing while receiving respiratory support (Nasal Cannula, HFNO, or PSV). Expected Significance: By comparing the lung images and ventilation/perfusion (V/Q) data from both methods, this study seeks to validate the reliability and precision of the non-apnea approach. This would allow clinicians to assess lung health in spontaneously breathing patients without interrupting their natural breathing rhythm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

March 19, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 24, 2026

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 13, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 13, 2026

Completed
Last Updated

April 23, 2026

Status Verified

January 1, 2026

Enrollment Period

25 days

First QC Date

March 18, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

Spontaneous BreathingLung PerfusionElectrical Impedance TomographyVentilation-Perfusion Matching

Outcome Measures

Primary Outcomes (1)

  • Spearman correlation coefficient (r)

    The Spearman correlation coefficient will be calculated to assess the voxel-by-voxel agreement of lung perfusion maps generated by the non-apnea algorithm compared to the reference standard (breath-hold method).

    Within 30 minutes

Study Arms (2)

Standard Breath-hold Method

ACTIVE COMPARATOR

1. This arm serves as the reference standard for EIT perfusion measurement. 2. A 10 mL bolus of 10% NaCl is injected during a 5-8 second end-expiratory pause. 3. For patients on Nasal Cannula or HFNO, the pause is achieved via coached respiratory instruction; for patients on PSV, the ventilator's end-expiratory hold function is used

Diagnostic Test: Saline-contrast EIT with a non-apnea algorithm

Non-apnea Method

EXPERIMENTAL

1. This arm evaluates the feasibility and accuracy of perfusion measurement during uninterrupted breathing. 2. A 10 mL bolus of 10% NaCl is injected while the patient maintains a natural, continuous breathing rhythm. 3. This method is tested across all included respiratory support modes, including Nasal Cannula, HFNO, and PSV, without any respiratory pause or instruction.

Diagnostic Test: Saline-contrast EIT with a non-apnea algorithm

Interventions

Participants receive a central venous bolus injection of 10 mL 10% NaCl. Lung perfusion is then assessed using Electrical Impedance Tomography (EIT). The intervention evaluates two acquisition conditions: one during a brief respiratory pause (reference) and one during uninterrupted spontaneous breathing (test).

Also known as: EIT Lung Perfusion Imaging
Non-apnea MethodStandard Breath-hold Method

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged ≥ 18 years.
  • Requiring respiratory support including Nasal Cannula, High-Flow Nasal Oxygen (HFNO), or Pressure Support Ventilation (PSV).
  • Hemodynamically stable.
  • Able to tolerate a brief respiratory pause (for the reference group).
  • Signed informed consent.

You may not qualify if:

  • Pregnancy or breastfeeding.
  • Contraindications to electrical impedance tomography (e.g., cardiac pacemaker, skin integrity issues on the chest).
  • Severe circulatory failure or cardiogenic shock.
  • Known allergy to hypertonic saline.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200025, China

Location

MeSH Terms

Conditions

Respiratory InsufficiencyCritical Illness

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hongping Qu

    Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2026

First Posted

March 24, 2026

Study Start

March 19, 2026

Primary Completion

April 13, 2026

Study Completion

April 13, 2026

Last Updated

April 23, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations